CPRF Year I ($40,000)
|
 |
RBC Foundation Research Award
Dr. Paul Arnold, University of Toronto
"Glutamate Neurotransmission in OCD: Genetic Study of a Candidate Biological System"
view summary
view press release
This project is funded through the generous support of RBC Foundation |
 |
Schizophrenia Research Award
Dr. David Mamo, University of Toronto
"Antipsychotic Polypharmacy in Schizophrenia"
view press release
This project is funded through the generous support of Schizophrenia Society of Canada.
|
 |
Dr. Erin Michalak, University of British Columbia
"Mood Monitoring as a Moderator of Relapse in Bipolar Disorder"
view press release |
 |
CIBC World Markets Children's Miracle Award
Dr. Dave Saint-Amour, University of Montreal
"Electrophysiological Assessment of Sensory Integration Autism"
view summary
view press release
This project is funded through the generous support of CIBC World Market's Children's Foundation
|
CPRF Year II ($40,000) |
|
|
Dr. Jorge Armony, McGill University, Douglas Hospital Research Centre
"Emotional Processing in PTSD and Remitted Individuals: An FMRI Investigation"
view press release |
 |
RBC Foundation Research Award
Dr. Sylvana Côté, University of Montreal Mary C. Early Fellow
"Associations Between Day Care Experiences and Children’s Mental Health: “The Role of Child Care Quality, Family Risk, and Children’s Individual Risks"
view summary
view press release
This project is funded through the generous support of RBC Foundation
|
 |
Dr. Gabriella Gobbi, McGill University
"Cannabis Exposure During Adolescence Alters Serotonin Neurotransmission and Emotional Behaviour in Adulthood"
view press release |
 |
Dr. Richard McCurdy, University of Toronto
"Gene Expression of Neuronal Progenitors in a 1q22-Linked Familial Subtype of Schizophrenia"
view summary
view press release
This project is funded through the generous support of the Robert E. Enos Foundation, Tom & Ruth Kritsch Family Foundation and Niagara Community Foundation Schizophrenia Research Fund. |
Partnered Awards: Year I ($100,000) |
Neurobiology of Psychiatric
Disorders and Addictions Program
These projects are funded jointly in partnership
with the following organizations:
|
 |
Dr. Paul Albert, University of Ottawa
"DNA methylation at a novel functional polymorphism of the serotonin-1A receptor gene promoter."
view press release |
 |
Dr. Diane Cox, University of Alberta
"NPAS3, encoding a brain transcription factor, as a causative gene for schizophrenia."
view press release |
 |
Dr. Steven Robert Laviolette, University of Western Ontario, Schulich School of Medicine
"Neural mechanisms of nicotine addiction and vulnerability: Role of dopamine transmission in the acute versus dependent phases of nicotine exposure."
view press release |
Partnered Awards: Year II ($100,000) |
|
Dr. Nicholas Barden, Laval University
“Role of Tyrosine Hydroxylase 2 (TPH2) in the Etiology of Affective Disorders”
view press release |
 |
Dr. Suzanne Erb, University of Toronto
"Effects of varying the interval Between a Reinstating Stimulus and the Opportunity to Seek Drug: An Animal Model of Relapse with Potential Treatment Implications"
view press release |
 |
Dr. Verner J. Knott, Royal Ottawa Hospital
"Effects of smoking history and acute nicotine on mood, arousal, and cognitive responses to Tryptophan depletion in depression-prone subjects."
view press release |
| |
